Literature DB >> 26238267

Long non-coding RNA HOTAIR: A novel oncogene (Review).

Xin Yu1, Zheng Li1.   

Abstract

Long non-coding RNAs (lncRNAs) have been found to be pervasively transcribed in the genome and are critical regulators of the epigenome. Increasing evidence suggests that lncRNAs are aberrantly expressed in several types of human cancer and that they are important in the initiation, development and metastasis of human cancer. Previous studies have revealed that HOX transcript antisense intergenic RNA (HOTAIR) was frequently upregulated in various types of cancer, including breast cancer, esophageal cancer, lung cancer and gastric cancer. In addition, patients with high expression levels of HOTAIR have a significantly poorer prognosis, compared with those with low levels of expression. HOTAIR is involved in the control of cell apoptosis, growth, metastasis, angiogenesis, DNA repair and tumor cells metabolism. The present review provides an overview of the current knowledge concerning the role of HOTAIR in tumor development and progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238267     DOI: 10.3892/mmr.2015.4161

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  55 in total

Review 1.  ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2016-01-11

2.  Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?

Authors:  Merdan Fayda; Mustafa Isin; Makbule Tambas; Murat Guveli; Rasim Meral; Musa Altun; Dilek Sahin; Gozde Ozkan; Yasemin Sanli; Husniye Isin; Emre Ozgur; Ugur Gezer
Journal:  Tumour Biol       Date:  2015-10-19

3.  LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.

Authors:  Juelan Wang; Wenqian Xu; Yangke He; Qi Xia; Siwei Liu
Journal:  Inflamm Res       Date:  2018-10-11       Impact factor: 4.575

Review 4.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

Review 5.  Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration.

Authors:  Zheng Li; Xingye Li; Chong Chen; Shugang Li; Jianxiong Shen; Gary Tse; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

6.  Long nonding RNA UCA1 regulates neural stem cell differentiation by controlling miR-1/Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Yu Liu; Mingqiu Wang; Yulan Zhu; Huaizhang Shi
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 7.  Long non-coding RNAs regulating macrophage functions in homeostasis and disease.

Authors:  Kaitlyn R Scacalossi; Coen van Solingen; Kathryn J Moore
Journal:  Vascul Pharmacol       Date:  2018-03-13       Impact factor: 5.773

Review 8.  Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overview.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Yi-Dan Lin; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 9.  Long non-coding RNAs in rheumatoid arthritis.

Authors:  Zheng Li; Xingye Li; Chao Jiang; Wenwei Qian; Gary Tse; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2017-11-07       Impact factor: 6.831

Review 10.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.